SENS Overview
Upcoming Projects (SENS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SENS)
-
A Second Opinion: Looking at the FDA approval of the Eversense 365 implantable Continuous Glucose Monitor from Senseonics
Tickers: SENS, ABT, DXCM, MDT
Executed On: Oct 11, 2024 at 04:00 PM EDT -
Looking at the FDA approval of the Eversense 365 implantable Continuous Glucose Monitor from Senseonics
Tickers: SENS, ABT, DXCM, MDT
Executed On: Oct 08, 2024 at 11:45 AM EDT -
A Second Look: Discussing Abbott Laboratories two new over-the-counter continuous glucose monitoring (CGM) systems – The Lingo and Libre Rio
Tickers: ABT, SENS, DXCM, MDT
Executed On: Jul 26, 2024 at 11:45 AM EDT -
Discussing Abbott Laboratories two new over-the-counter continuous glucose monitoring (CGM) systems – The Lingo and Libre Rio
Tickers: ABT, SENS, DXCM, MDT
Executed On: Jul 25, 2024 at 11:00 AM EDT -
Discussing implantable Continuous Glucose Monitors (CGMs) for patients with diabetes with a focus on Senseonics' Eversense CGM data
Tickers: SENS, ABT, DXCM, MDT
Executed On: Jul 26, 2023 at 01:00 PM EDT
Upcoming & Overdue Catalysts (SENS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SENS)
Strategic Initiatives (SENS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
